Foundations智能手机应用改善医护人员心理健康的英格兰多中心随机对照试验
该研究在16家NHS信托机构对医护人员开展多中心随机对照试验,评估Foundations应用对一般精神疾病患病率的效果。共1002人随机分配至应用组或等待名单对照组,随访894人(89.2%)。应用组在精神疾病症状、幸福感和失眠方面较对照组有改善,未报告不良事件。
要点
- 应用组精神疾病症状较对照组降低(aMD=-1.39,95%CI -2.05至-0.74)。
核心结论
- 在医护人员样本中,Foundations应用对减少精神疾病症状具有效果。
- 该应用可扩展且无不良效应,可能作为机构分层员工支持方案的一部分。
- 需要进一步证据评估长期有效性和成本效益。
研究设计与样本
- 多中心随机对照试验,在16家NHS信托机构招募医护人员(试验注册号:EudraCT: 2021-001279-18)。
- 参与者随机分配至Foundations应用组或等待名单对照组,在基线、4周和8周时评估。
- 主要结局为一般精神疾病患病率(使用General Health Questionnaire),采用混合效应多变量回归分析,以调整后平均差异(aMD)呈现。
主要发现
- 2021年3月22日至6月3日期间,1002名参与者被随机分配(500:502),894人(89.2%)完成随访。
- 随机分配至应用组的参与者精神疾病症状减少(aMD=-1.39,95%CI -2.05至-0.74)。
关键数值与推荐
- 主要结局采用General Health Questionnaire评估一般精神疾病患病率。
- 次要结局包括幸福感、出勤主义、焦虑、抑郁和失眠。
临床怎么用
- 鉴于该应用可扩展且无不良效应,可能作为机构分层员工支持方案的一部分使用。
局限性
- 需要进一步证据评估长期有效性和成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Healthcare workers (HCWs) have faced considerable pressures during the COVID-19 pandemic. For some, this has resulted in mental health distress and disorder. Although interventions have sought to support HCWs, few have been evaluated. AIMS: We aimed to determine the effectiveness of the 'Foundations' application (app) on general (non-psychotic) psychiatric morbidity. METHOD: We conducted a multicentre randomised controlled trial of HCWs at 16 NHS trusts (trial registration number: EudraCT: 2021-001279-18). Participants were randomly assigned to the app or wait-list control group. Measures were assessed at baseline, after 4 and 8 weeks. The primary outcome was general psychiatric morbidity (using the General Health Questionnaire). Secondary outcomes included: well-being; presenteeism; anxiety; depression and insomnia. The primary analysis used mixed-effects multivariable regression, presented as adjusted mean differences (aMD). RESULTS: Between 22 March and 3 June 2021, 1002 participants were randomised (500:502), and 894 (89.2%) followed-up. The sample was predominately women (754/894, 84.3%), with a mean age of 44⋅3 years (interquartile range (IQR) 34-53). Participants randomised to the app had a reduction in psychiatric morbidity symptoms (aMD = -1.39, 95% CI -2.05 to -0.74), improvement in well-being (aMD = 0⋅54, 95% CI 0⋅20 to 0⋅89) and reduction in insomnia (adjusted odds ratio (aOR) = 0⋅36, 95% CI 0⋅21 to 0⋅60). No other significant findings were found, or adverse events reported. CONCLUSIONS: The app had an effect in reducing psychiatric morbidity symptoms in a sample of HCWs. Given it is scalable with no adverse effects, the app may be used as part of an organisation's tiered staff support package. Further evidence is needed on long-term effectiveness and cost-effectiveness.
引用
- Gnanapragasam SN, Tinch-Taylor R, Scott HR, et al. Multicentre, England-wide randomised controlled trial of the 'Foundations' smartphone application in improving mental health and well-being in a healthcare worker population. Br J Psychiatry. 2023. PMID: 36040419. doi:10.1192/bjp.2022.103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。